To the Editor: We report the case of a 68-year-old woman with refractory diffuse large-B-cell lymphoma (DLBCL), germinal-center subtype, with a BCL2 rearrangement and multiple copies of MYC and BCL6. Her disease was refractory to intensive infusional chemotherapy, dose-adjusted etoposide,…
http://ift.tt/2vj1Y39
Πέμπτη 24 Αυγούστου 2017
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου